HOME >> BIOLOGY >> NEWS
Next generation of science stars: 5 female scientists receive 2006 LOral USA fellowships

New York, NY -- L'Oral USA announced today the recipients of its esteemed 2006 Fellowships for Women In Science at an awards ceremony at the American Museum of Natural History in New York City. Five young women, all on the cutting-edge of scientific advances, were awarded $20,000 each to carry out research projects. Now in its third year, the highly selective L'Oral USA Fellows program recognizes and rewards up-and-coming female scientists from across the country and disciplines.

While the scientific competence of men and women may be on an equal footing, there is an undeniable divergence between men's and women's careers in the sciences after they reach their late 20s and early 30s. At each successive stage on the career path, women drop out at higher rates than men. For women in science, the critical years occur during the transition from post-doctoral student to becoming a career scientist, which often coincides with starting a family. The L'Oral USA Fellowships encourage young women to continue their careers in science, by both supporting them financially and helping them strengthen their networks in the scientific community.

"The world benefits from many new discoveries that scientists and their research yield, and the need for trained scientists and researchers has increased," said Laurent Attal, President and CEO, L'Oral USA. "Women continue to be underrepresented in many important scientific disciplines and L'Oral believes that more can be done to encourage and support women in all fields of science. We firmly believe that science needs women."

Drawing from a competitive pool of talented post-doctoral researchers, the L'Oral USA Fellowships for Women In Science enable young scientists to continue working toward breakthroughs in their research. Women scientists like these Fellows often serve as inspirational role models, encouraging girls across the country to stay interested in science.

The 2006 L'Oral USA Fellows are:
'"/>

Contact: Brenda Timm
brenda.timm@edelman.com
212-704-4593
Edelman Public Relations
8-Jun-2006


Page: 1 2 3 4

Related biology news :

1. Cardiac patches stimulate regeneration, improve function after heart attack
2. Serica scientists win AOSSM Award for ACL (knee) tissue regeneration in preclinical study
3. Critical protein prevents DNA damage from persisting through generations
4. Early environmental exposure may accelerate age-related neurodegeneration
5. First demonstration of new hair follicle generation in an animal model
6. Enhanced environment restores memory in mice with neurodegeneration
7. Liver regeneration may be simpler than previously thought
8. Invasive grass may impede forest regeneration
9. Research project tackles regeneration gap
10. Whole body regeneration from a blood vessel
11. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists

Post Your Comments:
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
(Date:5/11/2015)... Ohio , May 11, 2015  Through a well-rounded ... Ohio had a strong showing at AUVSI,s Unmanned ... These representatives of Ohio,s UAS industry ... and abroad from all points along the UAS ecosystem. ... Development Coalition,s (DDC) Vice President for Aerospace Rich Knoll ...
(Date:5/10/2015)... GOTHENBURG, Sweden , May 11, 2015 ... touch fingerprint sensors FPC1025 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... the sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + 1 000 ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
(Date:5/21/2015)... Specialty Pharmacy Times has completed its ... BPA Worldwide as a business publication member. As ... for Specialty Pharmacy Times based on business/distribution, demographics ... member of BPA Worldwide, Specialty Pharmacy Times shows ... the most reliable, unequaled data,” said Chris Hennessy, ...
(Date:5/21/2015)... 21, 2015  The EveryLife Foundation for Rare ... and Amy Klobuchar (D-MN) today for ... & Treatments, or OPEN ACT. Supported ... organizations, this bipartisan legislation promises to rapidly bring ... rare disease patients by incentivizing drug makers to ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, ... distribution agreement with VWR to distribute TECTA™ B16, ... than 160 years of experience, VWR, a leading ... and production facilities, has cultivated a value proposition ... to enable science. Endetec’s TECTA™ B16, combines ...
Breaking Biology Technology:Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
Cached News: